Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 79937 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Partially Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Board of Scientific 

Counselors, National Cancer Institute. 

The meeting will be partially open to 

the public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://

videocast.nih.gov/). 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended for the review, discussion, 

and evaluation of individual intramural 

programs and projects conducted by the 

National Cancer Institute, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, National Cancer Institute. 

Date: November 4, 2024. 

Open: 10:00 a.m. to 10:30 a.m. 

Agenda: Remarks from the NCI Director. 

Closed: 10:30 a.m. to 4:40 p.m. 

Agenda: Personnel qualifications and 

performance, and competence of individual 

investigators. 

Address: National Institutes of Health, 

Building 31, C Wing, 6th Floor, Conference 

Room C, 9000 Rockville Pike, Bethesda, MD 

20892 (In-Person and Virtual Meeting). 

Contact Person: Brian E. Wojcik, Ph.D., 

Senior Review Administrator, Institute 

Review Office, Office of the Director, 

National Cancer Institute, 9609 Medical 

Center Drive, Room 3W414, Bethesda, MD 

20892, 240–276–5665, wojcikb@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: https://

deainfo.nci.nih.gov/advisory/bsc/index.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 25, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–22437 Filed 9–30–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; Career Awards (Ks) 

and Conference Support (R13) Review. 

Date: November 7, 2024. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Democracy II, Suite 200, 6707 Democracy 

Blvd., Bethesda, MD 20817. 

Meeting Format: Virtual Meeting. 

Contact Person: Alexander O. 

Komendantov, MS, Ph.D., Scientific Review 

Officer, National Institute of Biomedical 

Imaging and Bioengineering, National 

Institutes of Health, 6707 Democracy Blvd., 

Bethesda, MD 20892, (301) 451–3397, 

alexander.komendantov@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, National Institute of 

Biomedical Imaging and Bioengineering, 

National Institutes of Health.) 

Dated: September 25, 2024. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–22510 Filed 9–30–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Frederick National 

Laboratory Advisory Committee to the 

National Cancer Institute. 

The meeting will be held virtually 

and is open to the public. Individuals 

who plan to view the virtual meeting 

and need special assistance or other 

reasonable accommodations to view the 

meeting, should notify the Contact 

Person listed below in advance of the 

meeting. The meeting can be accessed 

from the NIH Videocast at the following 

link: https://videocast.nih.gov/. 

Name of Committee: Frederick National 

Laboratory Advisory Committee to the 

National Cancer Institute. 

Date: October 23, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: On going and new activities at the 

Frederick National Laboratory for Cancer 

Research. 

Place: NCI Shady Grove Conference Center, 

9609 Medical Center Drive, Rockville, MD 

20850 (Virtual Meeting). 

Contact Person: Christopher D. Kane, 

Ph.D., Health Science Administrator and 

Program Officer, Office of Scientific 

Operations, Frederick Office of Scientific 

Operations, National Cancer Institute, NIH, 

1050 Boyles Street, Building 427, Room 4, 

Frederick, MD 20872, christopher.kane@

nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: FNLAC: 

https://deainfo.nci.nih.gov/advisory/fac/ 

fac.htm, where an agenda and any additional 

information for the meeting will be posted 

when available. 


khammond on DSKJM1Z7X2PROD with NOTICES